Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder

@article{Lepola2004DoED,
  title={Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder},
  author={U. Lepola and A. Wade and H. Andersen},
  journal={International Clinical Psychopharmacology},
  year={2004},
  volume={19},
  pages={149-155}
}
Escitalopram is the S-enantiomer of citalopram. In this study, we compared the efficacy of equivalent dosages of escitalopram and citalopram in the treatment of moderate to severe major depressive disorder (MDD), based on data from two, pooled, randomized, double-blind, placebo-controlled studies of escitalopram in which citalopram was the active reference. The primary efficacy parameter was the mean change from baseline in the Montgomery Åsberg Depression Rating Scale (MADRS) total score… Expand
Efficacy and safety of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, randomized, double-blind, flexible-dose study
Efficacy of escitalopram compared to citalopram: a meta-analysis.
Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis
Superiority of escitalopram to paroxetine in the treatment of depression
Comparative efficacy of escitalopram in the treatment of major depressive disorder
  • M. Ali, R. Lam
  • Medicine
  • Neuropsychiatric disease and treatment
  • 2011
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 36 REFERENCES
Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care
Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care.
Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model.
Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo‐controlled study in depression in primary care
Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
A 24‐week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression
The safety and tolerability of citalopram
  • C. Muldoon
  • Medicine
  • International clinical psychopharmacology
  • 1996
The optimal dosing regimen for citalopram‐a meta‐analysis of nine placebo‐controlled studies
A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.
...
1
2
3
4
...